Supha Pharmachem MD, chairman, board of directors and AGM
BSE: 539561Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹0.25.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹21 Cr3,473rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 72,65,991
Supha Pharmachem board of directors
At the end of the quarter to Dec 2025, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonRambhajan Vishwakarma
6 directors3 independent2 executive1 non-executive
- Adarsh MunjalExecutive · joined Sep 2023 · 28 months as independent · 1 listed board
- Shamim Abdul MichalIndependent · joined Jan 2025 · 12 months as independent · 1 listed board · 1 as independent · 2 committee seats
- Bikram Kumar MundIndependent · joined May 2025 · 8 months as independent · 1 listed board · 1 as independent
- Vijay Pal Singh GulyaIndependent · joined May 2025 · 8 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Vignesh Laxman GawdeExecutive · joined Oct 2025 · 2 months as independent · 1 listed board
- Rambhajan Vishwakarma · ChairpersonNon-executive · joined Oct 2025 · 2 months as independent · 1 listed board · 2 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
6 directors who left
- Mansoor Vahab, left 29 Oct 2025: Others
- Dipesh Vaidya, left 6 Oct 2025: Others
- Seema Sanei, left 3 Jan 2025: Others
- Pratik Shah, left 3 Jan 2025: Others
- HANOSH SANTOK, left 31 Oct 2024: Others
- Trupti Bolke, left 31 Oct 2024: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 14 Nov 20253 of 6 present3 independent
- 31 Oct 20253 of 6 present3 independent
- 22 Sep 20254 of 6 present4 independent
Audit Committee
Chair Vijay Pal Singh Gulya
Shamim Abdul Michal, Rambhajan Vishwakarma
- 14 Nov 20253 of 3 present2 independent
- 4 Aug 20253 of 3 present2 independent
Nomination and remuneration committee
Chair Shamim Abdul Michal
Vijay Pal Singh Gulya, Rambhajan Vishwakarma
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair Rambhajan Vishwakarma
Shamim Abdul Michal, Vijay Pal Singh Gulya
- 14 Nov 20253 of 3 present2 independent
Risk Management Committee
Chair Shamim Abdul Michal
Adarsh Munjal, Vijay Pal Singh Gulya
- 14 Nov 20253 of 3 present2 independent
- 30 May 20253 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Tax disputes
Reported in the filing for the quarter to Dec 2025.
- Tax disputeDeputy Commissioner State GST for FY 2021-22Since 24 Oct 2024Appeal Filed and details sumited awaiting response from relevant authorityAt the filing before: Pending
- Tax disputeDeputy Commissioner State GST for FY 2020-21Since 24 Oct 2024Appeal Filed and details sumited awaiting response from relevant authorityAt the filing before: Pending
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2025. The company's results filing for the quarter to Sep 2025 says no statement of how money raised was used applies to it. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Rights IssuesMay 2025 | 47.88 | – | – | No |